See more : PAR Technology Corporation (PAR) Income Statement Analysis – Financial Results
Complete financial analysis of Vertex, Inc. (VERX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Vertex, Inc., a leading company in the Software – Application industry within the Technology sector.
You may be interested
- Unipos Inc. (6550.T) Income Statement Analysis – Financial Results
- Bukit Jalil Global Acquisition 1 Ltd (BUJAR) Income Statement Analysis – Financial Results
- State Street Corporation (STT) Income Statement Analysis – Financial Results
- Huntington Ingalls Industries, Inc. (HII) Income Statement Analysis – Financial Results
- Comet Resources Limited (CRL.AX) Income Statement Analysis – Financial Results
Vertex, Inc. (VERX)
About Vertex, Inc.
Vertex, Inc. provides tax technology solutions for corporations in retail, communication, leasing, and manufacturing industries in the United States and internationally. It offers tax determination, compliance and reporting, tax data management, document management, pre-built integration, and industry-specific solutions. The company sells its software products through software license and software as a service subscriptions. It also provides implementation and training services in connection with its software license and cloud subscriptions, transaction tax returns outsourcing, and other tax-related services. Vertex, Inc. was founded in 1978 and is headquartered in King of Prussia, Pennsylvania.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 572.39M | 491.62M | 425.55M | 374.67M | 321.50M | 272.40M |
| Cost of Revenue | 223.81M | 193.13M | 161.89M | 165.39M | 110.38M | 95.70M |
| Gross Profit | 348.58M | 298.49M | 263.66M | 209.28M | 211.12M | 176.71M |
| Gross Profit Ratio | 60.90% | 60.72% | 61.96% | 55.86% | 65.67% | 64.87% |
| Research & Development | 58.21M | 41.88M | 44.02M | 54.34M | 30.56M | 23.76M |
| General & Administrative | 145.94M | 121.65M | 107.01M | 149.06M | 71.01M | 58.95M |
| Selling & Marketing | 140.24M | 125.34M | 99.01M | 99.42M | 68.13M | 56.90M |
| SG&A | 286.17M | 246.99M | 206.01M | 248.48M | 139.14M | 115.85M |
| Other Expenses | 21.70M | 17.71M | 16.57M | 11.22M | 9.57M | 7.25M |
| Operating Expenses | 366.09M | 306.57M | 266.60M | 314.04M | 179.27M | 146.85M |
| Cost & Expenses | 579.81M | 499.71M | 428.49M | 479.42M | 289.65M | 242.54M |
| Interest Income | 0.00 | 1.68M | 984.00K | 1.72M | 1.08M | 526.00K |
| Interest Expense | 4.16M | 2.05M | 984.00K | 3.11M | 2.04M | 1.59M |
| Depreciation & Amortization | 74.46M | 76.28M | 56.73M | 32.22M | 25.19M | 24.90M |
| EBITDA | 56.95M | 53.07M | 41.84M | -72.54M | 58.13M | 22.07M |
| EBITDA Ratio | 9.95% | 10.80% | 9.83% | -19.36% | 18.08% | 20.10% |
| Operating Income | -7.42M | -8.08M | -2.94M | -104.76M | 31.86M | -2.83M |
| Operating Income Ratio | -1.30% | -1.64% | -0.69% | -27.96% | 9.91% | -1.04% |
| Total Other Income/Expenses | -14.25M | -2.05M | -984.00K | -3.11M | -953.00K | -34.41M |
| Income Before Tax | -21.67M | -10.13M | -3.93M | -107.87M | 30.90M | -4.43M |
| Income Before Tax Ratio | -3.79% | -2.06% | -0.92% | -28.79% | 9.61% | -1.63% |
| Income Tax Expense | -8.58M | 2.17M | -2.45M | -28.93M | 7.83M | 1.68M |
| Net Income | -13.09M | -12.30M | -1.48M | -78.94M | 23.08M | -6.11M |
| Net Income Ratio | -2.29% | -2.50% | -0.35% | -21.07% | 7.18% | -2.24% |
| EPS | -0.09 | -0.08 | -0.01 | -0.54 | 0.21 | -29.08 |
| EPS Diluted | -0.09 | -0.08 | -0.01 | -0.54 | 0.21 | -29.08 |
| Weighted Avg Shares Out | 151.86M | 149.65M | 147.78M | 146.44M | 146.17M | 210.00K |
| Weighted Avg Shares Out (Dil) | 151.86M | 149.65M | 147.78M | 146.44M | 146.17M | 210.00K |
Vertex (VERX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Vertex (VERX) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Vertex, Inc. (VERX) Q3 2024 Earnings Call Transcript
Vertex, Inc. (NASDAQ:VERX ) Q3 2024 Earnings Conference Call November 6, 2024 8:30 AM ET Company Participants Joe Crivelli - Vice President, Investor Relations David DeStefano - President & Chief Executive Officer John Schwab - Chief Financial Officer Conference Call...
4 GARP Stocks That Investors Can Scoop Up for Maximum Returns
Try the GARP strategy when seeking a profitable portfolio of stocks offering optimum value and growth investing. VERX, AXP, RJF and ADBE are some stocks that hold promise.
Vertex (VERX) Q3 Earnings and Revenues Surpass Estimates
Vertex (VERX) came out with quarterly earnings of $0.16 per share, beating the Zacks Consensus Estimate of $0.14 per share. This compares to earnings of $0.10 per share a year ago.
Vertex Announces Third Quarter 2024 Financial Results
KING OF PRUSSIA, Pa., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ: VERX) (“Vertex” or the “Company”), a leading global provider of indirect tax solutions, today announced financial results for its third quarter ended September 30, 2024.
Vertex Pharmaceuticals: Strong Execution Continued In Q3 But The Valuation Reflects It
Vertex reported strong Q3 results driven by the growth of the cystic fibrosis franchise and raised the full-year revenue guidance range by $100 million at the mid-point. Casgevy finally generated commercial revenue in Q3 and Vertex continues to work in...
Vertex Pharmaceuticals Beats Third-Quarter Estimates As Pain Treatment Looms
Vertex Pharmaceuticals beat third-quarter expectations on Monday. Though the company raised its sales outlook, Vertex stock was muted.
Vertex Pharma lifts annual revenue forecast on cystic fibrosis treatments strength
Vertex Pharmaceuticals raised its annual revenue forecast on Monday after it beat third-quarter estimates on demand for its cystic fibrosis (CF) treatments.
Vertex Reports Third Quarter 2024 Financial Results
BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today reported consolidated financial results for the third quarter ended September 30, 2024, and raised its full-year product revenue guidance to $10.8 billion to $10.9 billion. “The third quarter marked another period of strong...
Vertex Gears Up to Report Q3 Earnings: Is a Beat in the Cards?
VRTX's revenues in the third quarter of 2024 are likely to have been driven by the robust sales of its lead CF product, Trikafta/Kaftrio.
Source: https://incomestatements.info
Category: Stock Reports